Covid-19 vaccines targeting Omicron variants expected to be ready this autumn
Leading mRNA Covid-19 vaccine developers race to get their variant-specific boosters authorized, as newer subvariants start to become dominant.
By
Leading mRNA Covid-19 vaccine developers race to get their variant-specific boosters authorized, as newer subvariants start to become dominant.
ByThe team found that a TDZD compound could hinder the Mpro enzyme, which functions as a molecular scissor for viral…
With the latest development, more than 100 individuals in England and Wales will be eligible to receive imlifidase.
The latest findings showed that any drugs that can boost NCX3 activity could potentially decrease pain sensitisation in humans.
The researchers found that severe Covid-19 is mostly linked to a weakened response from two immune cells.
It’s been a turbulent year for gene therapies targeting rare diseases. Could two recent votes for bluebird bio signal a…
ByThe company plans to pursue an expedited approval as an obesity treatment after the recently approved diabetes drug shows weight…
ByThe health concern over COVID-19 in May 2022 decreased from April 2022, shows the COVID-19 concern index, which is measured…
Thank you for subscribing to Pharmaceutical Technology